Want to join the conversation?
$ENDP 2Q15 Call: Adjusted gross margin increased in the quarter when compared to the second quarter of 2014, primarily as a result of improved margins within our US generics business that offset by unfavorable trends in segment mix. Our adjusted operating expenses were approx. 22.5% of revenues, in line with our expectations.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)